| Annual · values | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -33.12 M USD | -33.97 M USD | -25.34 M USD | -29.20 M USD | -56.37 M USD | -137.08 M USD | -65.10 M USD | -52.73 M USD | -28.25 M USD | -2.29 M USD | -4.18 M USD |
| Depreciation & Amortization | 23000 USD | 4000 USD | 0 USD | 72000 USD | 109000 USD | 341000 USD | 350000 USD | 319000 USD | — | — | — |
| Stock-Based Compensation | 2.31 M USD | 3.30 M USD | 3.31 M USD | 4.30 M USD | 8.08 M USD | 18.10 M USD | 6.70 M USD | 3.64 M USD | 1.45 M USD | 573000 USD | 65000 USD |
| Capital Expenditures | 0 USD | 117000 USD | 0 USD | — | 0 USD | 113000 USD | 11000 USD | 140000 USD | 27000 USD | 31000 USD | 0 USD |
| Cash Flow from Investing | 37.37 M USD | 23.36 M USD | -57.35 M USD | 15.67 M USD | 1.03 M USD | 89.11 M USD | 41.37 M USD | -33.88 M USD | -15.06 M USD | -37.49 M USD | 0 USD |
| Cash Flow from Financing | -143000 USD | -141000 USD | 82.39 M USD | 1.65 M USD | 39.78 M USD | 61.81 M USD | 4.99 M USD | 125.91 M USD | 49.49 M USD | 0 USD | 47.72 M USD |
| Dividends Paid | — | — | — | — | — | — | — | — | — | — | — |
| Stock Buybacks | — | — | — | — | — | — | — | — | — | — | — |
| Free Cash Flow | -33.12 M USD | -34.09 M USD | -25.34 M USD | — | -56.37 M USD | -137.19 M USD | -65.11 M USD | -52.87 M USD | -28.27 M USD | -2.32 M USD | -4.18 M USD |
Vyne Therapeutics Inc. is a biopharmaceutical company dedicated to developing and commercializing innovative dermatology solutions. Primarily focused on the treatment of skin diseases, Vyne Therapeutics leverages its proprietary technologies to address conditions such as acne and rosacea. The company's commitment to advancing dermatological research is evident in its pipeline of therapeutic products that aim to enhance the care and management of skin conditions. By working closely with healthcare professionals and leveraging partnerships within the pharmaceutical industry, Vyne Therapeutics strives to deliver effective treatment options that improve patient outcomes. As an active participant in the biopharmaceutical market, Vyne Therapeutics plays a critical role in advancing dermatological therapies, contributing to the broader medical and healthcare sectors by providing solutions that benefit consumers and practitioners alike.